Duloxetine Capsule, Delayed Release
Product Images NDC 71610-403

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71610-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 60 mg (71610 0403 60)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure01 (Duloxetine Fig01)

Figure01 (Duloxetine Fig01)
The text describes a graph showing the proportion of patients who experienced a relapse over time in a study comparing a placebo with a drug called duloxetine. The x-axis measures the duration of time (in days) from randomization to relapse, while the y-axis measures the proportion of patients who relapsed. The study had 84 patients in the placebo group and 64 patients in the duloxetine group.*
FDA Label Image

Figure2 (Duloxetine Fig02)

Figure2 (Duloxetine Fig02)
The text represents a graph showing the proportion of patients with relapse in a clinical trial between a placebo group and a group taking Duloxetine. It also indicates the time from randomization to relapse in days.*
FDA Label Image

Figure03 (Duloxetine Fig03)

FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

FDA Label Image

Figure08 (Duloxetine Fig08)

Figure08 (Duloxetine Fig08)
The text appears to be a graph showing the percentage improvement in pain from baseline for patients taking Placebo and Duloxetine 60 mg once daily. The X-axis shows the percentage improvement while the Y-axis shows the number of patients. The graph shows that Duloxetine 60 mg was more effective in reducing pain compared to Placebo.*
FDA Label Image

Figure09 (Duloxetine Fig09)

Figure09 (Duloxetine Fig09)
This is a description of a drug called Duloxetine taken once daily in doses of 60 or 120 mg for treating pain. The drug is placed in a comparison with Placebo. The rest of the text is a chart representing numbers regarding the drug's effectiveness on pain treatment.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.